Literature DB >> 32298171

A Low-Barrier and Comprehensive Community-Based Harm-Reduction Site in Vancouver, Canada.

Michelle Olding1, Andrew Ivsins1, Samara Mayer1, Alex Betsos1, Jade Boyd1, Christy Sutherland1, Coco Culbertson1, Thomas Kerr1, Ryan McNeil1.   

Abstract

"The Molson" is a low-barrier, peer-staffed, supervised consumption site located in Vancouver, Canada. In addition to overdose response, this site offers drug checking and a colocated injectable hydromorphone treatment program, and it distributes tablet and liquid hydromorphone to service users at high risk of overdose. Our evaluation suggests benefits of this program in creating service continuums and preventing overdose deaths. From September 2017 to August 2019, the site had 128 944 visits, reversed 770 overdoses, and had no overdose deaths.

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32298171      PMCID： PMC7204455          DOI： 10.2105/AJPH.2020.305612

Source DB:  PubMed          Journal:  Am J Public Health        ISSN： 0090-0036            Impact factor:   9.308


  6 in total

1.  Safety profile of injectable hydromorphone and diacetylmorphine for long-term severe opioid use disorder.

Authors:  Eugenia Oviedo-Joekes; Suzanne Brissette; Scott MacDonald; Daphne Guh; Kirsten Marchand; Salima Jutha; Scott Harrison; Amin Janmohamed; Derek Z Zhang; Aslam H Anis; Michael Krausz; David C Marsh; Martin T Schechter
Journal:  Drug Alcohol Depend       Date:  2017-05-10       Impact factor: 4.492

Review 2.  Heroin on trial: systematic review and meta-analysis of randomised trials of diamorphine-prescribing as treatment for refractory heroin addiction†.

Authors:  John Strang; Teodora Groshkova; Ambros Uchtenhagen; Wim van den Brink; Christian Haasen; Martin T Schechter; Nick Lintzeris; James Bell; Alessandro Pirona; Eugenia Oviedo-Joekes; Roland Simon; Nicola Metrebian
Journal:  Br J Psychiatry       Date:  2015-07       Impact factor: 9.319

3.  Peer worker involvement in low-threshold supervised consumption facilities in the context of an overdose epidemic in Vancouver, Canada.

Authors:  Mary Clare Kennedy; Jade Boyd; Samara Mayer; Alexandra Collins; Thomas Kerr; Ryan McNeil
Journal:  Soc Sci Med       Date:  2019-02-10       Impact factor: 4.634

4.  The implementation of overdose prevention sites as a novel and nimble response during an illegal drug overdose public health emergency.

Authors:  Bruce Wallace; Flora Pagan; Bernadette Bernie Pauly
Journal:  Int J Drug Policy       Date:  2019-01-29

5.  The cost-effectiveness of Vancouver's supervised injection facility.

Authors:  Ahmed M Bayoumi; Gregory S Zaric
Journal:  CMAJ       Date:  2008-11-18       Impact factor: 8.262

Review 6.  Supervised injection facilities in Canada: past, present, and future.

Authors:  Thomas Kerr; Sanjana Mitra; Mary Clare Kennedy; Ryan McNeil
Journal:  Harm Reduct J       Date:  2017-05-18
  6 in total
  12 in total

1.  Motivations to initiate injectable hydromorphone and diacetylmorphine treatment: A qualitative study of patient experiences in Vancouver, Canada.

Authors:  Samara Mayer; Al Fowler; Isabella Brohman; Nadia Fairbairn; Jade Boyd; Thomas Kerr; Ryan McNeil
Journal:  Int J Drug Policy       Date:  2020-09-16

2.  Implementation of Safe Supply Alternatives During Intersecting COVID-19 and Overdose Health Emergencies in British Columbia, Canada, 2021.

Authors:  Ryan McNeil; Taylor Fleming; Samara Mayer; Allison Barker; Manal Mansoor; Alex Betsos; Tamar Austin; Sylvia Parusel; Andrew Ivsins; Jade Boyd
Journal:  Am J Public Health       Date:  2022-03-09       Impact factor: 9.308

3.  Health impacts of a scale-up of supervised injection services in a Canadian setting: an interrupted time series analysis.

Authors:  Mary Clare Kennedy; Kanna Hayashi; M-J Milloy; Miranda Compton; Thomas Kerr
Journal:  Addiction       Date:  2021-12-02       Impact factor: 6.526

4.  "You need money to get high, and that's the easiest and fastest way:" A typology of sex work and health behaviours among people who inject drugs.

Authors:  Shannon N Ogden; Miriam Th Harris; Ellen Childs; Pablo K Valente; Alberto Edeza; Alexandra B Collins; Mari-Lynn Drainoni; Matthew J Mimiaga; Katie B Biello; Angela R Bazzi
Journal:  Int J Drug Policy       Date:  2021-05-10

5.  Factors associated with 60-day adherence to "safer supply" opioids prescribed under British Columbia's interim clinical guidance for health care providers to support people who use drugs during COVID-19 and the ongoing overdose emergency.

Authors:  Marion Selfridge; Kiffer Card; Taylor Kandler; Erin Flanagan; Emily Lerhe; Ash Heaslip; Anne Nguyen; Matthew Moher; Bernie Pauly; Karen Urbanoski; Chris Fraser
Journal:  Int J Drug Policy       Date:  2022-05-04

6.  Tackling the overdose crisis: The role of safe supply.

Authors:  Andrew Ivsins; Jade Boyd; Leo Beletsky; Ryan McNeil
Journal:  Int J Drug Policy       Date:  2020-05-01

7.  Barriers and facilitators to a novel low-barrier hydromorphone distribution program in Vancouver, Canada: a qualitative study.

Authors:  Andrew Ivsins; Jade Boyd; Samara Mayer; Alexandra Collins; Christy Sutherland; Thomas Kerr; Ryan McNeil
Journal:  Drug Alcohol Depend       Date:  2020-09-15       Impact factor: 4.492

Review 8.  Peer Support and Overdose Prevention Responses: A Systematic 'State-of-the-Art' Review.

Authors:  Fiona Mercer; Joanna Astrid Miler; Bernie Pauly; Hannah Carver; Kristina Hnízdilová; Rebecca Foster; Tessa Parkes
Journal:  Int J Environ Res Public Health       Date:  2021-11-17       Impact factor: 3.390

9.  Integration of a community-based harm reduction program into a safety net hospital: a qualitative study.

Authors:  Ghulam Karim Khan; Leah Harvey; Samantha Johnson; Paul Long; Simeon Kimmel; Cassandra Pierre; Mari-Lynn Drainoni
Journal:  Harm Reduct J       Date:  2022-04-12

Review 10.  To what extent do supervised drug consumption services incorporate non-injection routes of administration? A systematic scoping review documenting existing facilities.

Authors:  Kelsey A Speed; Nicole D Gehring; Katherine Launier; Daniel O'Brien; Sandy Campbell; Elaine Hyshka
Journal:  Harm Reduct J       Date:  2020-10-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.